SCHEMBL6515410

SCHEMBL6515410

Cc1cc(C)nc(NC(N)=NCCc2ccc(Oc3ccccc3)cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.56
ATP4A P20648 1/20 0.43
ATP4B P51164 1/20 0.43
ALDH1A1 P00352 6/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 3/20 0.41
KDM4E B2RXH2 1/20 0.41
PHGDH O43175 3/20 0.41
SCN5A Q14524 1/20 0.41
SCN2A Q99250 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
RAB9A P51151 3/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6511300 0.77 ADORA2A (0.64) ADORA2AATP4AATP4BALDH1A1HTT
SCHEMBL5923332 0.77 EPHX2 (0.49) ALDH1A1LMNAKMT2AKDM4EPHGDH
SCHEMBL6510332 0.76 KMT2A (0.55) ATP4AATP4BALDH1A1KMT2APHGDH
SCHEMBL2801062 0.74 ADORA2A (0.73) ADORA2AATP4AATP4BALDH1A1LMNA
SCHEMBL6507381 0.73 RAB9A (0.54) ADORA2AATP4AATP4BLMNAKMT2A
SCHEMBL6514076 0.72 ADORA2A (0.52) ADORA2AATP4AATP4BALDH1A1HTT
SCHEMBL5923207 0.71 SMN1; SMN2 (0.52) ALDH1A1HTTLMNAKMT2AKDM4E
SCHEMBL6518566 0.70 CYP1A2 (0.56) ALDH1A1LMNAKMT2AKDM4EPHGDH
SCHEMBL6510602 0.70 MAPK1 (0.63) LMNAKMT2AKDM4EPHGDHSCN2A
SCHEMBL6508975 0.69 MEN1 (0.53) ALDH1A1HTTLMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed